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CHAPTER I 
INTRODUCTION 
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Lead possesses unique properties that were to make it one of the 
most useful industrial metals in Greek and Roman times. Because of its 
corrosion resistance and formability, it was used extensively in plumbing 
architecture, ship building, and for stationery. Its density and malleability 
made it attractive for making plummets, s inkers , and standard weights. 
The utilization of lead reached such an impressive level during the period 
of the Roman empire that lead is often referred to as a "Roman metal". 
The usage of lead in the Roman empire exceeded 550 grams per person per 
year. The cumulative worldwide production of lead from the earliest times 
to the fall of the Roman empire has been estimated to be about 40 million 
tons. 
Because of the toxic properties of lead, the price for its utilization 
has often been high. The first person to commercialize metaJ'lic lead was 
probably poisoned by the lead fumes from his or her Kiln or furnace, and 
undoubtedly generations of artisans throughout antiquity who worked with 
this dangerous metal received the same rude treatment. It is estimated 
that the number of workers who were occupationally exposed to lead during 
the period of the Roman empire was over 140,000 per year. Considerably 
higher fractions of lead using populations were exposed to lead contamination 
in their food and drink. The Roman preseved their fruits and vegetables 
with lead sa l t s , cooked their foods in leaded pots . They added lead to 
their wines to stop further fermentation, to impart color or bouquet, or 
to blunt the acidity of an errat ic brew. Their water was delivered in lead 
pipes, while saturnine cosmetics and medicaments were common and quite 
popular. With such overexposure to lead, we find frequent l i terary 
references to epideirnricsof plumbism and saturnine gout among the members 
of the Roman aristocracy. Excessive use and exposure to lead is believed 
to be one of the main causes of fall of Roman empire. 
Toxic response to lead exposure may be modified by external variables 
such as socio-economic conditions, nutritional status and environmental 
stress * . The anemia is well known effect of Pb poisoning in humans 
and Fe deficiency anemia is most common among children and industrial 
workers. The specific diagnostic tests are necessary to distinguish between 
iron deficiency anemia and lead induced anemia common among children and 
industrial workers in developing countries.At present, it is difficult to 
distinguish between Fe deficiency and Pb induced anemia on the basis of 
hematological and enzymatic al terat ions. While basic features of Fe deficiency 
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anemia now being well understood, the interaction of Fe deficiency anemia 
and Pb exposure, remains obscured. Low dietary Fe tends to increase the 
susceptibil i ty to Pb intoxication due to enhanced gastro-intestinal absorption 
( 3 4 ) 
of lead ' . Recently, itt was observed that Pb sensitive hematological 
parameters vary as a function of Fe status in children with severe Pb 
. . ( 5 ) • 
poisoning 
The development of an anemia, usually of the hypochromic normocytic 
type is of common occurrence in lead poisoning . However, the character-
ist ics of the . induced anemic syndrome appear to vary with the stage and 
(7) 
course of the intoxications . Lead anemia predominently results from 
defective hemoglobinization although it may also feature accelerated e ry thro-
(8) 
cyte destruction notably in acute pediatr ic plumbism . This is compatible 
with the evidence of a detrimental action of large doses of lead on mature 
(9) circulating red cells both in vitro as well as in vivo 
The various hematological and biochemical aspects related to lead-induced 
derangement in hemoglobin synthesis have been extensively outlined in a 
number of reviews .The structural conterpart of this synthetic defect 
is the damaging action of lead upon the erythroblast ic cells of the bone 
marrow where the hemin moiety is elaborated. Morphological evidence of 
lead-induced disrupted erythropoietic function, is the formation of immature 
red cel ls , the appearance of iron-stainable inclusions in a considerable 
portion of the erythroblasts and an abundancy of punctate basophilic 
stippling in the erythrocyte precursor ce l l s . Secondary to the abnormal 
deposition of iron granules and basophilic stippling in marrow reticulum 
(17) 
cel ls , there is an increased frequency of siderocytes and stippled 
(18) 
cells among the circulating erythrocytes in experimental and human 
plumbism. Lead dyshemetopoiesis is reflected by a number of biochemical 
(19) abnormalities i . e . an exaggerated r ise in the excretion of ALA , Copro-
porphyrin III ' and occasionally of uroporphyrin I , elevation of 
erythrocyte protoporphyrin and raised levels of ALA and iron 
in the blood and plasma. Various types of prophyrins , but mainly copro-
porphyrin accumulate in the blood and tissue during experimental 
(26-28) poisoning , The r ise in ALA excretion in conjunction with the absence 
of gross deviation in the urinary output of PBG, is pathognomonic of lead 
porphyria, which differentiates it diagnostically from chemical porphyr ias . 
Because of their early appearance, several of these parameters serve as 
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valuable indices for the detection and diagnosis of excess lead absorption. 
The interaction of Fe deficiency and Pb intoxication rnay be interesting 
as Fe status influences the absorption, retention and toxic manifestations 
of Pb . Only recently has an understanding of the relationship between 
lead ingestion, iron deficiency and overt intoxication begun to emerge. 
Similar to lead exposure, iron deficiency anemia is common among metal 
ore miners, industrial workers and children particularly in developing 
countries. 
Iron deficient and the lead poisoned subjects share the common charac-
ter is t ics of low blood hemoglobin and elevated protoporphyrins. As such, 
hematological examination of such population offers no clue for diagnosis 
of the type of anemia. Prevalence of such anemia among general population 
especially children, calls for development of diagnostic tests to characterise 
specifically the iron deficiency and lead induced anemia for proper clinical 
management. The possibil i ty exists that , under diverse exposure and defi-
ciency s tates , changes induced by lead exposure or iron deficiency, might 
be mimicked by each other . 
Lead 
Lead is the most abundent of the heavy metals in the e a r t h ' s crust 
and also is one of the oldest metals used by mankind. The important lead 
minerals are galena (lead sulfide) ,cerrusite(l<2ad carbonate) .angl is i tedead 
sulfate), and also found in crocoisite(the chromates) ,wulfenite(the 
molybdate),pyromorphlte(the phosphate) ,matlockite(the chloride) and vanadi-
nite(the vanadate) .There is a certain natural background concentration of 
lead in the physical and the biological environment due to its mobilization 
and dissemination from these deposites. The major lead mining countries 
are United States of America, USSR,Australia,Canada,Peru,Mexico,China,Yugo-
slavia and Bulgaria. 
Chemical Characteristics 
Atomic Weight 207 
Specific Gravity 11.25-11.4 
Melting Point 327''C 
Boiling Point - 1620'C 
The maximum allowable concentrations 
Metallic lead 0.2 mg per Cm 
Lead arsenate 0.15 mg per Cm 
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Sources of lead exposure 
Environmental Water 
Air 
Soil 
Food 
Household Crayons and Toys 
Paper and Clothes 
Dirt and Sand 
Paint F lakes 
Furni ture 
Wallpaper 
Lead-Glazed Di shes ,Cups ,Glas ses e t c . 
Persons at High Industrial Risk 
Miners 
Smelters 
Automobile F i n i s h e r s 
Storage Bat tery Workers 
Sheet Metal Workers 
Spray Pa in te r s 
Lead is ex t ens ive ly used in p r in t i ng , manufacture of p a i n t s , wa t e r -
p i p e s , s t o r a g e b a t t e r y , po t t e ry and so lder ing o p e r a t i o n s . Besides i t is used 
in the manufadture of l i t h a r g e r u b b e r , i n s e c t i c i d e s , p l a s t i c s , var ious a l loys 
and a lso in chemical i n d u s t r i e s . T e t r a e t h y l lead (Pb (C-H_) . ) (TEL) is t he 
2 5 4 
chief organic compound used , as an ant i -knock a d d i t i v e to motor fuels and 
is cons idered hazardous during t h e p rocess of mixing of TEL with motor 
fuel. 
Lead poisoning can give r i s e to a v a r i e t y of chemical syndromes in 
man depending on the chemical n a t u r e , d o s e and length of lead e x p o s u r e . 
The c l in ica l manifestation of lead poisoning include anemia along with o the r 
symptoms of poisoning l ike acute abdominal colic and syndrome of acute 
encepha lopa thy . 
Charactractics of lead poisoning 
Acute lead poisoning (rare) 
Sweet metal l ic t a s t e 
Sal ivat ion 
Vomiting In tes t ina l Colic 
Chronic lead poisoning (Plumbism) 
-5 -
Hematologlcal Basophilic stippling,Hypochronic normocytic Anemia 
Neurological (lead Encephalopathy) 
Ataxia, Nausea, Vomiting, Restlessness, I r r i l ab i l i ty , Convulsions, Coma 
Gastrointestinal (Lead Colic) 
Anorexia,Constipation,Mettalic Taste 
Neuromuscular 
Lead Palsy,Wrist Drop,Foot Drop,Fatigue Muscular Weakness 
Renal 
Fanconi like syndrome (Reversible) 
Chronic Nephritis ( I r revers ible) 
Effect of lead on heme-biosynthesis 
One of the best known toxic effect of lead on living creatures, is 
i ts interference with heme synthesis . The action of primary importance 
is the interference of lead with mitochondrial function, which depresses 
the synthesis of the cytochromes the mitochondrial respiratory pigments 
present in nearly every cell of the body. The interference of lead with 
heme synthesis may result in the development of anemia. This , however, 
is a late symptom of lead intoxication. 
One of the best studied effects of lead on heme synthesis is i ts inter-
ference with the last step of th is chain, the insertion of the iron into 
protoporphyrin, mediated by the enzyme ferrochelatase,which is located 
in the inner matrix of mitochondria. Present evidence suggests that this 
effect results from the inhibition by lead of the transmitochondrial transport 
of iron . As a result , the mitochondria become iron-deficient, and instead 
of producing, in an orderly fashion, heme they accumulate large amounts 
of i ts precursor, protoporphyrin, which lacking iron, is incapable of perfor-
ming the essential respiratory function. As a result of lead intoxication 
in these cel ls , protoporphyrin takes the place of- heme in the specific 
pocket of the hemoglobin molecule. This large accumulation of protoporphyrin 
in the red cells can be used to diagnose lead intoxication easi ly . Protopor-
phyrin is present as its free base,but as the red cells remain in circula-
tion, zinc is rapidly chelated at the center of the molecule in the site 
usually occupied by iron. Ultimately, therefore,in lead intoxication, there 
is in the red cel ls ,a large concentration of zinc-protoporphyrin. 
Another enzyme of the heme synthetic pathway, S'-amino-levulinic 
acid dehydratase ( S-ALAD),has also been shown to be affected by lead. 
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The inhibition of heme production by lead 
Succinyl Co A + Glycine 
ALA Synthe tase 
Excre ted in the ur ine <- ^-Aminolevulinic acid 
I 
5-Aminolevulinic Acid^--
d e h y d r a t a s e 
Porphobi l inogen 
Uroporphyrinogen III 
Excreted in the urine<- Co-proporphyr inogen III 
P r o t o p o r p h y r i n IX 
.Fe"2 
F e r r o c h e l a t a s e 4 - -
Heme 
—-^inhibited 
by lead 
inh ib i t ed 
by lead 
- ro -
This enzyme is so sens i t i ve to lead tha t i t s a c t i v i t y is reduced by one-half 
even at n low blood lead level of 15 u g / d l . The inh ib i t ion of the enzyme 
6'-ALAD lead to an increased arrnmiilntinn of it.'^  r.iibr.trntr, ^-AI.A, In llin 
pl.iMii.i .IIKI b»><ly I liihl:;, wllli a C()II:;C<|IIOMI Increased excre t ion of {)"-ALA 
in the u r i n e . 
The diagnost ic ind ica tors of lead poisoning a r e the presence of inclusion 
bodies in s ide rocy te s and sideroblcxsts .negat ive cor re la t ion between blood 
(32) lead and serum i ron,enhanced u r o p o r p h y r i n s in bone marrow .enhanced 
u r ina ry excre t ion of 5'-aminolevulinic a c i d , i n h i b i t i o n of blood S'-aminolevulinic 
acid d e h y d r a t a s e . 
The ba soph i l i c s t ipp l ing obse rved in the red ce l l s of i nd iv idua l s 
with lead poisoning has been exp la ined by the inh ib i t ion by lead of p y r i m i -
dine nucleot idase an enzyme r e spons i ab l e for the c leavage of r e s idua l nucleo-
(33) t ides . The fast moving hemoglobin de tec ted in i nd iv idua l s wi th lead 
(34) 
poisoning is now known t6 consis t of hemoglobin molecules t ha t contain 
(35) 
p ro topo rphy r in ins tead of heme . The hemols i s a s soc ia ted with lead 
poisoning has been shown to resu l t from the combination of inh ib i t ion of 
py r imid ine nucleot idase , t h e damage to the red cel l membrane .and 
(37) 
the inh ib i t ion of the red cell ATP ase . The combination of a l l t h e s e 
V 
abnormal i t ies leads to anemia. 
Lead exposure r e p o r t e d l y induced renal tubular dysfunction causing 
e x c e s s i v e excre t ion of amino ac ids ,g lucose and p h o s p h a t e , i n h i b i t i o n of e r y -
th rocy t e membrane Na ,K ATP ase in people with only modera te ly e leva ted 
, . (38,39) 
lead exposure 
Iron Metabolism 
Iron is an essent ia l component of haemoglobin and a lso of myoglobin 
and var ious i ron-containing enzymes. It occurs wide ly in foods of animal 
and vege tab le o r ig in , la rgely in organic form. Absorp t ion of iron t akes place 
mainly in the duodenum and upper jejunum. The b i o a v a i l a b i l i t y of iron is 
high in d i e t s r ich in animals foods and dec reases as the p ropor t ion of 
food of vegatable or igin in the d ie t i n c r e a s e s . The average absorp t ion of 
iron from indiv idua l vege tab le foods ranges from 1% to 6% whereas from 
meats under comparable condi t ions i t ranges from 7% to 22% ~ . I n eggs , 
(43) iron a p p e a r s to be much less a v a i l a b l e . The amino acid composit ion 
- 1 1 -
of the diet,and particularly the level of cysteine,may be important. These 
studies also show the value of foods of animal origin,not only on account 
of the high availabil i ty of meat iron, but also of the enhancing effect of 
these foods on the absorption of vegetable iron. 
(44) The total body iron content of normal adult males is 3-4 g . Most 
of this iron,about 65-67% is in the form of hemoglobin,3-5% is in the myo-
globin of muscle,a small amount is in haem enzymes (Cytochrome, Catalase,a 
nd peroxidase),about 30% is in the non-haem compounds ferrit in and haemo-
siderin,and a very small amount (about 0.07%) is bound to transferrin. 
Iron stores (haemosiderin and transferrin) reach their lowest level between 
12 and 20 months of age during childhood but during adolescence they 
increase slowly and reach adult levels in males around 20 years of age. 
Because of the additional iron requirements imposed by menstruation and 
pregnancy .most women during their reproductive life have considerably lower 
iron stores than men living on a similar diet . 
Iron deficiency anaemia 
As iron deficiency and iron deficiency anaemia are the result of a 
lack of balance between dietary iron absorption and iron requirements, includ-
ing iron loss,preventive measures against this deficiency should be oriented 
towards improving the diet in respect of iron absorption and reducing the 
pathological loss of iron. Recent studies have suggested that those indivi-
duals with mild iron deficiency may have subnormal mean corpuscular hemo-
(45) globin concentration . It has been demonstrated that when such subjects 
are fed medicial i ron, their mean corpuscular hemoglobin concentration (MCHC) 
r i s e s . Therefore, hemoglobin concentration and MCHC have been successfully 
routinely applied to large population samples in extensive field testing 
for mild iron deficiency. 
Iron deficiency in the developing countries is more than just a nutr i -
tional problem. The issue of general' sanitation and its relation to parasi t ic 
infestation with considerable and chronic iron loss is a major factor in 
the pathogenesis of iron deficiency. Iron deficiency is primarily-a nutritional 
problem or chronic iron loss due to parasi t ic infestation or due to 
malabsorption. 
•12-
Several studies have shown that good results can be obtained by 
the administration of small amounts of iron to schoolchildren even when 
they are heavily infested with paras i tes . 
Classification of iron deficiency 
Four stage of iron deficiency can be conveniently considered 
1. Prelatent: Characterized by a reduction of the bone marrow haemo-
siderin and an increased intestinal absorption of inorganic iron. At 
this stage there is no anemia and serum iron and transferrin saturation 
remain normal. 
2. Latent: This more advanced state of iron deficiency is characterized 
by a reduction of the percentage transferrin saturation as a consequence 
of the diminution of the serum iron level and an increase of the 
unsaturated iron binding capacity (UIBC). 
3. Early anaemia; The hemoglobin concentration in the peripheral blood 
is reduced to 11-10 g per 100 ml of blood, morphological changes in 
the red cells are slight or absent and the MCHC remains above 30%,and 
there is a further decrease of the percentage transferrin saturation 
in the plasma. 
4. Marked Anemia; At this stage the hemoglobin concentration in the blood 
is below 10 g per 100 ml of blood and the percentage transferrin 
saturation is even lower. Changes in the red cells are evident and 
characterized by a reduction of the hemoglobin content and a diminution 
in size of the red ce l l s . These morphological changes are reflected 
in a reduction of the MCHC below 30%. 
Interrelationship between iron and lead 
Iron deficient animals are more susceptible to lead toxicity than iron-
(47) 
replete animals . Iron deficiency resulted in an increased retention of 
lead in l iver , kidney and bone and led to enhanced urinary excretion of 
lead. Biochemical alterations due to lead toxici ty, including urinary excretion 
of -ALA were greater in iron-deficient rats fed lead than in rats receiving 
adequate diets and lead . The data was directly suggesting that iron 
-13-
deficiency enhanced gastrointestinal absorption of lead and may even increase 
cellular transport of lead. The iron deficient diet enhances the intestinal 
transport and absorption of some other metals,namely .iron,manganese cobalt 
, . (49-51) 
and zinc 
Study on young rats fed iron-deficient diet until their tissue iron 
(52) 
stores were part ial ly depleted and lead exposed revealed that iron 
probably competes with lead for absorptive sites in the intestinal mucosa. 
This effect is probably not at tr ibutable to intraluminal physical changes 
of lead but it is more likely that lead and iron share a common absorption 
receptor. The intestinal absorption of lead in iron-supplemented rats is 
(53-55) thus decreased . It has been pointed out that ferri t in limits the 
absorption and facilitates the storage of unneeded iron. Interaction of lead 
with ferritin results in a displacenent of hydrogen ion and precipitation 
of a complex with a maximum binding capacity of 400 atoms of lead per 
molecule of ferr i t in. In iron-deficient rats,only 6% of liver lead was ferri t in 
bound. The decrease in lead absorption after iron supplementation was asso-
ciated with decreased toxicity indicated by improvement in weight gain 
and survival . The binding of lead by ferritin in intestinal muscosa cells 
and their exofoliation may explain the decreased absorption of lead following 
iron supplementation. Oral administration of ferrit in similarly diminished 
lead absorption. 
CHAPTER II 
MATERIALS AND METHODS 
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Chemical s 
The biochemicals procured from Sigma Chemical Co.St . Louis,USA 
were , 6-ALA,Dowex res ins ,GSH-Px , reduced GSH and NADPH. 
Methyl isobutyl Ketone from Fluka .Germany,Potass ium cyanide from 
May and Baker , England, Ammonium Pyr ro l id ione d i th ioca rbamate from 
BDH,England and DPD from "Loba Chemie, India" were used in the 
s t u d y . The ox id i sed cytochrome-C was from CSIR cent re for b iochemi-
c a l s . New De lh i , I nd i a . The buffer sa l ts ,TCA and ac ids for t i s sue d i g e s -
tion and assay were of h ighes t pu r i t y ana ly t ica l g rade and procured 
from S.Merck/Sisco Research Labo ra to r i e s , Ind ia . The O-phosphor i c 
acid A.R. was from G l i n d i a , I n d i a . Digitonin was from Sear l e , England. 
The d ie t components l ike s u c r p s e , c a s e i n , c o r n s t a r ch e t c . were from 
Sisco Research Labo ra to r i e s , Ind ia . All o ther reagents were procured 
local ly and were of ana ly t ica l g r a d e . 
-15-
Animals and Treatment 
Female albino r a t s (70 ± 10 g) bred in I . T . R . C . colony were used in 
the s t u d y . They were equal ly d iv ided into four g roups . The animals of groups 
II and IV were fed Fe deficient syn the t i c d ie t (Table I) and subjected to 
o rb i t a l p leuxes puncturing twice a week, for two weeks to allow lowering of 
blood hemoglobin content (7-8 g/100 m l ) . The animals of group I. and III w e r e , 
however .maintained on Fe sufficient d ie t (Table I ) . The rea f t e r , t he animals were 
t r ea t ed for next s ix weeks as fo l lows : -
Group I - Fe sufficient d ie t (control) 
Group II - Fe deficient d ie t 
Group III - Fe sufficient d ie t 
+ 
0.1% Pb (OOC.CH ) .3H O in dr inking water 
Group IV - Fe deficient d ie t 
+ 
0.1% Pb (OOC.CH ) . 3 H 0 in dr inking wa te r . 
At the end of 3 and 6 weeks , s ix animals from each group were kep t 
i nd iv idua l ly in metabolic cages for 24 h r . u r ine col lect ion and k i l l ed t h e r e a f t e r . 
The blood was col lec ted in hepar in ized v i a l s and l i v e r . k i d n e y , h e a r t , f e m u r 
and hind limb muscles exc ised out . Tissues were washed with normal sa l ine 
and s tored at -20''C for the es t imat ion of me ta l s . The t i s sue homogenates were 
p r e p a r e d using pot te r -Elvehjem homogenizer f i t ted with teflon p e s t l e . 
Enzyme assays 
1. Blood ^-aminolevulinic acid dehydratase (9-ALAD) 
The a c t i v i t y of S-ALAD was determined by the method of Berl in 
and S c h a l l e r ^ ^ ^ ^ 
The assay system consis ted of 0.4 ml hepa r in i zed blood and 1.1 ml 
d i s t i l l e d w a t e r . The mixture was p re - incuba ted at 37°C for 10 min.for 
complete hemolys i s . Now 1.0 ml of ^-ALA solution (0.083 g ALA in 50 
ml of phospha te buffer 0.1 M pH 6.4) was added to the exper imenta l 
t u b e s , w h i l e 1 ml of TCA was added to control blank tubes (10% TCA, 
containing 1.35 g HgCl ) . The react ion was al lowed to proceed for 60 min. 
at 37''C and terminated by add i t ion of 1 ml TCA to exper imenta l tubes 
and 1 ml ALA solution to blank t u b e s . The tubes were ch i l l ed for 10 min . , 
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TABLE 1 
Chemical Composition of Diet 
Ingredients g/kg 
Casein 
Corn starch 
Sucrose 
Groundnut Oil 
Mineral mixture 
B Vitamin mixture 
Choline ch lo r ide 
DL-Methionine 
F e S 0 . . 7 H , 0 in sucrose 4 2 
220 
370 
300 
50 
45 
10 
1.5 
2.0 
1.5 
A - Modified AIN-76 mineral mixture,B-AIN-76 Vitamin mix tu re , Analytical 
grade FeSO .7H O t r i t u r a t e d in powdered sucrose (1.5g) to supp ly 35mg 
or 5mg F e / k g , d i e t for iron sufficient or iron def ic ient d ie t r e s p e c t i v e l y . 
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centrifuged at 2000 rpm for 5 tnin. and 1 ml of r e su l t an t supernatant t r a n s -
fe r red to another tube .To each supernatant f rac t ion, 1 ml of E h r l i c h ' s 
reagent (0 .5 gm dimethylaminobenza ldehyde in 12.5 ml ace t ic acid + 6 
ml p e r c h l o r i c acid + 1 ml 2.5 % HgCl in ace t ic ac id ,vo lume made upto 
20 ml with acet ic a c i d ) . The color was allowed to deve lop for 5 min. 
and absorbance read at 555 nm. The enzyme a c t i v i t y was e x p r e s s e d as 
mole S-ALA/min/1 e r y t h r o c y t e s . 
2. Hemoglobin (Hb) 
(57) Blood Hb was measured by the method of Clegg and King . 0.02 
ml blood was mixed with 5 ml of D r a b k i n ' s reagent and the absorbance 
read at 540 nm. The Hb content was e x p r e s s e d as g/lOOml b lood . 
3. Packed Cell Volume (PCV,Hematocrit) 
/ C O \ 
Blood PCV was determined according to Keele and Neil . F r e s h l y 
drawn blood was f i l led in microhaematocr i t c a p i l l a r i e s and spun at 3000 
rpm in a microcentrifuge for exac t ly 3 min. The packed cel l volume 
e x p r e s s e d as % of blood volume was measured on a haematocr i t reading 
s c a l e . 
4. Blood Zinc Protoporphyrin (ZPP) 
Blood ZPP was measured with a d rop of fresh blood on a p r e c a l i b r a -
(59) ted g lass s l i d e placed on the assigned slot of heamotoflurometer 
The values were e x p r e s s e d as g ZPP/g Hb. 
5. Urinary Q'^iiino levulinic acid (S-ALA) 
Urinary ALA was es t imated as d e s c r i b e d by Davies et a l . . Urine 
samples col lected in d i s p o s a b l e p l a s t i c tubes . ac id i f i ed and s tored at 4''C 
unti l ana lyzed . To ach ieve quan t i t a t ive separa t ion of S-ALA,the ur ine 
samples were passed through dual chromatography columns set up in tendem 
pos i t ion . The top column contained Dowex 2x8 anion exchange r e s in whi le 
the bottom column had Dowex 50x8, cation exchange r e s i n . Following passage 
of ur ine sample (5-8 ml) through both t h e columns,each column was washed 
with 10 ml deionized water X 3 t imes . The top column was removed 
and ALA eluted from bottom cat ionic column with 7 ml 1 M sodium a c e t a t e . 
The eluate thus obtained was mixed with 0.2 ml f r e sh ly d i s t i l l e d ace ty l 
acetone and placed in a boil ing water bath for 10 min . , cooled under 
running wa te r . To each tube 5 ml of f r e sh ly p r e p a r e d E h r l i c h ' s reagent - I I 
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(1 g p -d imethy laminobenza ldehyde in 30 ml glacial ace t ic acid. + 
8 ml 70% p e r c h l o r i c acid and made upto 50 ml with glacial ace t ic 
ac id) was a d d e d . The color was read after 10 min. at 555 nm. The 
values were e x p r e s s e d as mg ALA/24 h r s u r ina ry exc re t i on . 
6. Blood and Tissue Lead 
Lead was es t imated in blood . l i v e r . k idney . sp leen and femur by 
the method of Yeager et a l . . 3-5 ml blood or 0 .5-1 .0 g of t i s sue 
was acid d iges ted by repea ted addi t ion of acid mixture (HNO :HCIO.; 
6 : 1 ) . The acid d iges ted carbon- f ree e x t r a c t was made upto 5 ml 
with deionized wa te r . To each e x t r a c t , 5 ml of ammonium c i t r a t e 
buffer (pH 8.5) was mixed followed by few d r o p s of ammonia 
so lu t ion , to r a i s e the pH 7-8. Subsequent ly , 1 ml of 10% potassium 
cyanide solution was added to mask the in te r fe rence of i ron , zinc 
and coppe r . The solutions were vigourously shaken and 1 ml of 
f resh ly p r e p a r e d 2% Ammonium p y r r o l i d i n e d i th ioca rbamate (APDC) 
added for lead complexat ion. F i n a l l y , l e a d was e x t r a c t e d into 4 ml 
of water sa tu ra ted methy l i sobu ty l Ketone. The working s t andard (1-4 
ppm) and reagent b lanks were put through same ex t r ac t ion p r o c e d u r e . 
The samples were read at 283.3 nm on atomic absorp t ion s p e c t r o p h o t o -
meter (Pe rk in -E lmer -5000) . 
7. Zinc,Copper and Iron in Tissues 
Zn.Cu and Fe were es t imated by the method of Pa rke r et a l . 
Tissues (1-1 .5 g) were acid d iges ted as de ta i l ed in the preceding 
p a r a g r a p h . After appropjr iate d i l u t i o n , t h e samples were d i r e c t l y 
a s p i r a t e d , i n t o atomic absorp t ion spec t ropho tomete r (Perkin-Elmer-5000) 
using mixture of ace ty lene and a i r . The wavelength chosen for Zn,Fe 
and Cu were 213.9 nm,248.3 nm and 324.7 nm r e s p e c t i v e l y . 
8. Plasma Cholesterol 
Free and p s t e r i f i e d cho les te ro l were measured as d e s c r i b e d by 
z l ak i s et a l . * . The procedure followed was as de ta i l ed be low-0 .5 
ml plasma was mixed with 9.5 ml of acetone-ethanol mixture (1:1) 
and placed in a water bath at 60-70°C for 10 min . , coo led and volume 
adjusted to 10 ml with acetone-ethanol mix tu re . An a p p r o p r i a t e a l iquot 
(2 ml for total 
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choles te ro l and 5 ml for free cho les t e ro l ) was evapora ted to near d r y n e s s 
at 80°C in a water b a t h . The fract ions for to ta l cho les te ro l were d i s so lved 
in 6 ml glacial ace t ic a c i d . To each such f rac t ion , 4 ml of color reagent 
(1 ml of 10% FeCl .6H O solution in acet ic a c i d , w a s mixed with cone. 
H SO and volume made up to 100 ml with ac id) was added and the color 
2 4 
read after 20 min. at 570 nm. Now, for the es t imat ion of free c h o l e s t e r o l , 
the near d ry res idue or iginat ing from 5 ml solut ion, was made upto 1 
ml with acetone-ethanol mix ture ,and mixed with 1 ml digi tonin solution 
(1% in 50% v / v e thano l ) , allowed to stand for 10 min . , spun at lOOOxg 
for 10 m i n . , r e s i d u e washed with 4 ml acetone, spun again, supernatant 
decanted , r es idue placed on water bath (50°C) for complete d r y i n g . To 
the d r i ed r e s i d u e , 7 , 5 ml of glacial acet ic acid was a d d e d , al lowed to 
stand in the water bath for 5 min. for complete so lub i l i za t ion . An a l iquot 
of 6 ml of the c lear solution was t r ans f e r r ed to another tube and mixed 
with 4 ml color reagent . Appropr ia te b lanks and s t anda rd solut ions were 
s imi la r ly processed and r e a d at 570 nm. 
Plasma Ceruloplasmin (Cp) 
The ceruloplasmin l eve l s were measured according to Curzon and 
Valet . The assay comprised of 1 ml plasma {20xdiluted with 0.1 M 
sa l i ne ) , 2 ml sodium aceta te buf fe r ,0 .2 M,pH 5.5 and volume made up to 
4 ml with deionized wa te r . The a p p r o p r i a t e b lanks were a lso r u n , s u b s t i t u t -
ing sal ine in place of p lasma. After a 5 min. pre incubat ion at 37 ' 'C , reac-
tion in i t i a ted with 1 ml 1.7m M N-N ' -d ime thy l -p -pheny lened i amine (DPD), 
allowed to run for 15 min. and terminated by add i t ion of 2 ml sodium 
azide {0.3m M in 10% s a l i n e ) . The absorbance was read at 550 nm. One 
unit of a c t i v i t y was equiva lent to opt ica l dens i ty change of 0 .01/min/ml 
plasma. 
10. Total Plasma Iron (TI) and Iron Binding Capacity (TIBC) 
The total plasma iron and ir 
according to Pe te r s and Giovannicello 
on binding capac i ty were determined 
(65,66) 
Total Plasma Iron (TI) 
Two ml plasma was ac id i f ied with 3 ml of 0.2 N HCl, followed by 
addi t ion of 0.05 ml th iog lyco l ic a c i d . After 30 min, 1 ml 30% TCA was 
a d d e d , t h e suspension spun at lOOOxg for 10 min. An al iquot of 4 ml 
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supernatant was taken in a g lass tube ,mixed with 0.5 ml sa tu ra ted sodium 
aceta te and 2 ml ba thophenan thro l ine solution (0.02%). The color was 
read after 10 min. at 535 nm. Appropr i a t e blanks and s t anda rd solut ions 
were s imi l a r ly p r o c e s s e d . Total iron was e x p r e s s e d as mequ Fe/100 ml 
p lasma. 
Total Iron Binding Capacity (TIBC) 
One ml plasma was t r ans fe r r ed to a clean tube and mixed with 0.1 
ml f e r r i c ammonium c i t r a t e (equivalent to 0.05 mg Fe) and allowed to 
s tand for 10 min. Now about 0.5 ml of r e s in suspension (Dowex 50x8,H ) 
was added and mixed tho rough ly . To each f rac t ion , 5 ml b a r b i t a l buffer 
(0.04 M,pH 7.5) was a d d e d , s t i r r e d for 5 min. spun at lOOOxg for 5 
min. To five ml of resu l tan t superna tan t , 0.05 ml of th iog lyco l ic acid 
was added for complete conversion of Fe to Fe , al lowed to stand 
for 30 min and ac id i f i ed with 1 ml 30% TCA, spun 15 min. l a te r at lOOOxg 
for 10 min. An al iquot of 4 ml supernatant was mixed with 0.5 ml sodium 
aceta te ( sa tu ra t ed ) solut ion,fol lowed by 2 ml ba thophenan th ro l ine solution 
(0.02% solution in p ropano l : Isoam.yl a l c o h o l , 3 : 1 ) , t h e color was al lowed 
to deve lop for 10 min . , and read at 535 nm. Approp r i a t e b lanks and 
s t anda rds were concurrent ly run. The iron binding capac i ty was e x p r e s s e d 
as mequ. Fe/100 ml p lasma. 
11 . Blood Glutathione Pe rox idase (GSH Px) 
Glutathione pe rox idase a c t i v i t y was determined according to the 
(67) 
coupled assay of Paglia and ValentiT^e . F re sh ly drawn blood (0 .5 ml) 
was spun at lOOOxg for 5 min . , pe l le t washed t h r i c e with normal sa l ine 
and suspended in 0.5 ml normal s a l i ne . The rbc suspension was lysed 
with 9 volumes of ch i l l ed deionized water and d i lu ted 1:1 with D r a b k i n ' s 
reagent . This was used as the enzyme source . The a s say system comprised 
of: 0.70 ml phospha te buffer ,pH 7 .4 ,0 .25 M,containing "1 unit of g lu ta th ione 
r educ ta se ; 0.05 ml reduced g lu ta th ione , 40 m M; 0.01 ml NADPH,20 m M; 
0.30 ml deionized wa te r ; 5 A»1 RBC l y s a t e , m i x e d t h o r o u g h l y , p r e i n c u b a t e d 
for 5 min, and react ion in i t i a t ed by addi t ion of 20 JX-l of t - b u t / 1 p e r o x i d e . 
The p e r o x i d a s e a c t i v i t y was measured at 340 nm, by following ox ida t ion 
of NADPH. The react ion was followed eve ry 30 s e c . over a per iod of 
4 min. The enzyme a c t i v i t y was e x p r e s s e d as mole NADPH ox id i zed /min /ml 
blood. 
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12. Succinate dehydrogenase (SDH) 
The succinate dehydrogenase a c t i v i t y was measured according 
(68) 
to s l a t e r and Bonner . A 10% (w/v ) homogenate of l i v e r , k i d n e y , 
hea r t and muscles in 0.25 M i ce-co ld sucrose was p r e p a r e d and 
spun at 700xg for 15 min. The resu l t an t supernatant was used as 
the source of enzyme. The assay mixture comprised of 0.3 ml 0 - p h o -
spho r i c acid 0.5 M; 0.3 ml potassium f e r r i c y a m i d e , 0.01 M; 0.3 
ml potassium c y a n i d e , 0 . 1 M; 0.1 ml sodium succinate , 0.1 M; and 
water 1.8 ml. The react ion was in i t i a ted by the addi ton of 0.2 
ml enzyme. The opt ica l dens i ty change at 400 nm. was recorded 
at eve ry 1 min. in te rva l and monitored for 6 min. The average 
per min. op t ica l dens i ty change between 1 min. and 5 min. was 
taken for ca lcu la t ions . The a c t i v i t y was e x p r e s s e d as nmole potassium 
fe r r i cyan ide reduced/min/mg p ro t e in . 
13; Succinate Cytochrome-C-Reductase 
The succinate cytochrome C reduc tase a c t i v i t y was measured 
according to Hatefi et a l . . A por t ion of l i v e r was homogenised 
in 0.25 M sucrose containing 3.4 mmole t r i s -HCl pH 7 .4 , t o obta in 
101 (w /v ) homogenate. The homogenate was spun at TOOxg for lOmin. 
, t he pe l le t washed with homogenizing medium and centrifuge again. 
The combined supernatant was spun at 10,000 g for 30 m i n . , t h e 
pe l le t suspended and spun again. The resu l tan t pe l l e t was f inal ly 
resuspended in homogenizing medium to obtain mi tochondr ia l fract ion 
(10% w / v ) . This mi tochondria l fract ion was used as the enzyme 
source . The assay system comprised of 0.4 ml phospha t e buffer , 
0.25 M containing 5 mM EDTA;0.02 ml sodium azide.lOO m ^ : 0.10 
ml sodium ace ta te ,50 mM; deioized water to make volume to 0.9 
ml; 0.05 ml ox id ized cytochrome C (2 mg/ml ) ; and af ter 5 min.of 
p r e incuba t ion , t he react ion in i t i a t ed by add i t ion of 100 >JLl of d i lu ted 
enzyme (1;10 d i l u t i o n ) . The reduct ion of cytochrome C was measured 
at 550 nm. One unit of a c t i v i t y cor responded to op t ica l dens i ty 
change of 1 /min/g , f resh t i s s u e . 
CHAPTER III 
RESULTS 
• 2 2 -
Dietary Fe deficiency significantly increased the activity of blood 
ALAD which was more pronounced at 3 weeks than at 6 weeks. The exposure 
to Pb on the other hand .significantly inhibited this enzyme, the levels 
of which were of almost similar order at both time intervals examined. 
However,the Pb induced inhibition in ALAD was completely offset by Fe 
deficiency in animals exposed to Pb and fed Fe deficient diet . The Pb 
exposure caused elevation in blood ZPP level which was proportional to 
the duration of exposure. The Pb induced increase in blood ZPP was more 
marked in animals fed Fe deficient diet . The Fe deficiency alone however, 
had no effect on blood ZPP level . The animals fed Fe deficient diet showed 
a significant decrease in blood PCV and Hb contents both at 3 and 6 weeks. 
While the animals exposed to Pb and maintained on Fe sufficient diet 
showed a decrease in PCV only after 6 weeks. The Pb exposure upto 6 
weeks could not lower blood Hb content significantly. However, the effect 
of Fe deficiency-Pb exposure on blood PCV and Hb content was similar 
to that produced by Fe deficiency alone (Table 2). 
The blood GSH-Px level decreased while the urinary excretion of 
ALA increased significantly during Fe deficiency or Pb exposure. While 
the combination of the two factors further increased the urinary eX^cretion 
of ALA,it did not show any synergistic effect on blood GSH-Px levels . 
The feeding of Fe deficient diet during Pb exposure significantly increased 
the uptake of Pb in blood. The blood level of Pb increased with the 
duration of exposure (Table 3). 
Plasma ceruloplasmin-a copper binding protein was significantly 
lowered by Fe deficiency or Pb exposure and a synergistic effect was 
observed in animals exposed to Pb and fed Fe deficient d ie t . The total 
plasma cholesterol level increased significantly in response to Fe deficiency 
or prolonged Pb exposure (6 weeks). The fractionation of total cholesterol 
into free and esterified form revealed that the enhancement in total plasma 
cholesterol was mainly due to an increase in the free form. The animals 
exposed to Pb and maintained on Fe deficient diet showed a further 
increase in plasma "cholesterol level. The Fe deficiency or Pb exposure 
decreased plasma Fe and increased total Fe binding capacity. These effects 
were more marked in animals exposed to Pb and fed Fe deficient diet 
(Table 4) . 
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The feeding of Fe deficient diet decreased the activity of SDH in 
muscle and liver but increased in kidney. The exposure to Pb in animals 
fed normal diet inhibited the hepatic SDH only. As Pb alone had no influ-
ence on muscle SDH,"the inhibitory effect of Fe deficient diet reduced signi-
ficantly in animals exposed to Pb and fed Fe deficient diet . Similarly,the 
effect of Fe deficiency on renal SDH persisted in animals exposed to Pb 
and fed Fe deficient diet,though Pb alone had no influence on renal SDH. 
Interestingly, the inhibitory effect of Fe deficient diet or Pb alone on 
hepatic SDH vanished in animals exposed to Pb and fed Fe deficient diet . 
The animals fed Fe deficient diet showed an increase in the activity of 
hepatic succinate cytochrome C reductase after 3 weeks which returned 
to normal during next 3 weeks. However, the effect of Fe deficiency on 
hepatic cytochrome C reductase remained predominent in animals exposed 
to Pb and fed Fe deficient diet ,while Pb alone had no influence on this 
enzymeCTable 5). 
The accumulation of Pb in l iver , kidney, spleen and femur increased 
with the duration of Pb exposure. The dietary deficiency of Fe significantly 
enhanced Pb accumulation which was also related to the duration of t rea t -
ment (Table 6) . 
The feeding of Fe deficient diet decreased the endogenous hepatic 
and renal Zn levels,which was significant after 6 weeks. The exposure 
to Pb also decreased the hepatic Zn both at 3 and 6 weeks while it 
increased the renal Zn during first 3 weeks only. However, the animals 
administered Pb and fed Fe deficient diet showed an increase in hepatic 
Zn level as compared to those fed Fe deficient diet alone at 6 weeks and 
a decrease in renal Zn as compared to those exposed to Pb and maintained 
on normal diet at 3 weeks. Spleen Zn levels remained unaffected by all 
the treatments (Table 7) . 
The Fe deficient diet feeding reduced the endogenous hepatic and 
spleen Cu levels . The exposure to Pb reduced the hepatic Cu but increased 
spleen Cu as observed after 6 weeks in animals maintained on normal diet . 
However, the lowering effect of Fe deficient diet on spleen Cu enhanced 
when the animals were exposed to Pb and fed Fe deficient diet . The renal 
Cu levels remained unaltered except the lowering observed in animals 
administered Pb and fed Fe deficient diet at 3 weeks (Table 8) . 
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The animals fed Fe deficient diet alone showed a decrease in Fe 
levels of l iver ,kidney and Spleen. The exposure to Pb decreased renal 
Fe and spleen Fe.the latter was significant only at 3 weeks. The synergism 
in the effects of Pb and Fe deficient diet could be observed only in liver 
and kidney at 6 weeks (Table 9) . 
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Regression Analysis 
Linear r eg ress ion ana lys i s of the data (10) showed the following s ign i f i -
cant co r re l a t ions -
i) Blood Pb vs plasma Fe in Pb exposed animals fed normal d ie t (r= -
1.10, p 0.01 at 3 w e e k s ) . As the blood Pb concentrat ion i n c r e a s e s , t h e 
plasma Fe level dec reases (F ig . l a ) . 
i i ) Plasma Fe vs plasma free cho les te ro l in Pb exposed group maintained 
on normal d ie t (r= - 0 .97 ,p 0.01 at 6 w e e k s ) . As the plasma Fe dec reases 
due to Pb t o x i c i t y , t h e plasma cho les te ro l inc reases (F ig . l b ) . 
i i i ) Blood Pb vs blood ZPP in Pb exposed group fed normal d ie t (r= - 0 .80 ,p 
0.05 at 6 w e e k s ) . The blood ZPP level inc reases with the concentrat ion 
of blood Pb (F ig . I c ) . 
iv ) Plasma Fe vs blood Pb in Pb exposed animals maintained on Fe def ic ient 
d ie t (r = - 0 .86 ,p 0.05 at 6 w e e k s ) . As the plasma Fe d e c r e a s e s the 
blood Pb concentrat ion increases (Fig . 2 a ) . 
v) Plasma Fe vs plasma free cho les te ro l in Pb exposed animals fed Fe 
deficient d ie t (r= - 0 .47 ,p 0.05 at 3 weeks ; r= - 0 .83 ,p 0.05 at 6 
w e e k s ) . The plasma cho les te ro l level inc reases with the dec rea se in 
plasma Fe level (F ig . 2 b , c ) . 
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DISCUSSION 
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The Fe metabolism is a conservation based system and thus the 
most common cause of Fe deficiency is the loss of normal conservation 
of Fe. The hematopoietic alterations occur in Fe deficiency as well as 
Pb exposure and mostly the effects are overlapping and common. The 
excessive Pb concentrations and Fe deficiency have an effect on Hb level 
and RBC size. However, concur rent Fe deficiency appears to be the most 
potent factor producing microcytic anemia that is quite prevalent among 
children with severe Pb poisoning. The present study involved mapping 
of certain selected parameters to investigate the possible interaction 
of Fe deficiency and Pb poisoning as evaluated by the overall effects 
on metabolites or enzyme concentrations. 
(71) While Fe deficiency increased the activity of blood ALAD ,the 
Pb exposure decreased it and their effects seem to be antagonistic to 
eachother. The observation emphasizes the need for caution in using this 
parameter as a biological indicator of Pb exposure during Fe deficiency,a 
situation not uncommon particularly in the developing countries. Chaleve-
(72) lakis et a l . also observed an increase in ALAD activity in e ry thro-
cytes of patients with Fe deficiency anemia. ALAD is a substrate inducible 
enzyme but iron deficiency is expected to impair ALA formation 
Thus, the increased ALAD activity is not likely to be due to a substrate 
concentration effect. The urinary ALA levels however, were significantly 
elevated in both the situations which suggests that two different pheno-
mena might operate in Fe deficiency and Pb poisoning. The first relates 
to the inhibition of blood ALAD by Pb resulting in enhanced urinary 
excretion of its substrate,ALA. The other possibil i ty is that due to the 
increase in blood ALAD activity during Fe deficiency, the physiological 
demand for ALA may also go-up which might necessitate increased produc-
tion of ALA through ALA synthetase. The production of ALA might outpace 
the utilization of this substrate by Fe deficiency induced blood ALAD-
resulting in the increased excretion of urinary ALA. 
The inhibitory effect of Fe deficiency or Pb intoxication on the 
red blood cell GSH-Px suggests marked oxidative s t ress to these cells 
under both the conditions. However, there appears to be no synergistic 
effect of the two factors. The depressing effect of Fe deficiency or Pb 
exposure on Cu binding protein-ceruloplasmin indicates that Cu status 
is influenced very efficiently by such insults and that many metabolic 
alterations could be attributed indirectly to the altered Cu metabolism. 
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The increased cholesterol synthesis during Fe deficiency and on prolonged 
Pb exposure appears to be a secondary effect. The metals have been 
found to stimulate hepatic synthesis of cholesterol . A strong negative 
correlation as evidenced by regression analysis between plasma Fe and 
blood Pb and between plasma Fe and plasma free cholesterol in Pb 
exposed animals maintained either on normal or Fe deficient diet substan-
tiates the concept of Pb-Fe absorption antagonism. The significant lowering 
in plasma total Fe and increase in total Fe binding capacity in animals 
exposed to Pb and fed Fe deficient diet reflects a positive synergistic 
action of Pb and Fe deficiency. The marked uptake of Pb during Fe 
deficiency demostrated that decreased Fe levels enhance Pb absorption 
and suggest that under normal physiological s ta te ,Pb and Fe share common 
gastrointestinal absorption pathway. 
The present study has shown that decrease in blood-GSH-Px,PCV, 
Plasma-ceruloplasmin and-Fe levels and increase in urinary excretion 
of ALA, plasma-cholesterol and-total iron binding capacity are common 
characterstics of both Fe deficiency and Pb intoxication and thus have 
limited use as specific diagnostic parameter for either of them. However, 
increase in the activity of blood ALAD with no change in ZPP level 
appears to be specific effect of Fe deficiency. On the other hand, inhibi-
tion in the activity of blood ALAD with an increase in ZPP level may 
serve as diagnostic indicator of Pb intoxication. Even in situations where 
Pb poisoning and Fe deficiency co-exist one would expect significantly 
higher activity of blood ALAD. 
The activity of SDH,a Fe dependent enzyme altered in muscle, l iver 
and kidney during dietary Fe deficiency. The lowering of muscular SDH 
reflects a direct effect of Fe deficiency and may be regarded as its 
specific indicator. However, this effect was countered by the concurrent 
exposure to Pb. Though, Fe containing enzymes or those requiring i ts 
presence for optimal activity account for a very small proportion of the 
total body Fe, there is evidence that impaired function of such enzymes 
(76 77) 
and associated metabolic pathway may result from Fe deficiency ' 
The fact that hepatic mitochondrial succinate cytochrome C reductase 
activity increased during Fe deficiency but not upon Pb exposure shows 
that Pb does not influence the mitochondrial enzyme systems. Neverthe-
less , Fe deficiency does not cause general decrease in the levels of 
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mitochondrial constituents despite marked structural changes in l iver 
(78) 
mitochondria . The feeding of Fe deficient diet for 14 weeks resulted 
in a decrease in the activity of only succinate cytochrome C reductase 
(79) 
among mitochondrial electron transport reactions 
The fact that Fe deficient diet during Pb exposure significantly 
enhanced the uptake and retention of Pb in various organs and flat bone 
as observed at 3 and 6 weeks and that Pb showed potentiating effect 
in lowering hepatic and renal Fe levels particularly at 6 weeks of feeding 
Fe deficient diet,strongly suggest that under physiological conditions,Pb 
and Fe share common gastrointestinal absorption pathway and the deficiency 
of Fe increases the body burden of Pb. The lowering of tissue Zn levels 
by dietary Fe deficiency as well as upon Pb exposure may alter Zn-
associated physiological functions. The Zn deficiency has been reported 
(80 81) to impair growth and protein synthesis in humans and animals ' 
The observation that there was no synergistic effect of Fe deficiency 
and Pb exposure on hepatic and renal Cu levels,suggests that homeostasis 
of Cu is maintained in these organs despite the dual insult. 
CHAPTER IV 
Summary and Conclusion 
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The ancient civilizations of Egypt .Greece, India and China are 
known to have smelted and used lead for vessels,roofs .water ducts, 
utensils, ornaments and weights. The Romans used lead extensively 
in the transport of water and the storage of wine and food. Excessive 
use and exposure to lead is believed to be one of the main causes 
of fall of Roman empire. The increase in dissemination of lead into 
the environment, consequent to rapid industralization.from stationary 
and mobile sources, has resulted in concern about the toxicological 
significance of body burdens of lead insufficient to cause overt 
plumbism but experienced by large numbers of individuals in the 
general population; The greater affluence and economic growth support 
the demand for a higher quality of life.including better standards 
of health and safety at work and in the community. 
Toxic response to lead exposure may be modified by external 
variables such as nutritional status and environmetal s t r e s s . Children 
with lead poisoning frequently have iron deficiency and anemia,but 
to what extent the conditions are interactive is unclear. Anemia 
is a common feature of both lead poisoning and iron deficiency. 
While the basic features of Fe deficiency anemia now being well 
understood, the interaction of Fe deficiency and Pb exposure, remains 
obscured. Such an interaction seems to be of importance. Similar 
to lead exposure, iron deficiency anemia is common among metal ore 
miners, industrial workers and children particularly in developing 
countries. 
Iron deficient and the lead poisoned subjects share the common 
characterist ics of low blood hemoglobin and elevated protoporphyrins. 
As such, hematological examination of such population offers no clue 
for diagnosis of the type of anemia. Prevalance of such anemia among 
general population especially chi ldren,cal ls for development of diag-
nostic tests to characterize specif ical ly, the iron deficiency and lead 
induced anemia for proper clinical management. The possibi l i ty exis ts 
that,under diverse exposure and deficiency s ta tes , changes induced 
by lead exposure or iron deficiency,might be mimicked by each 
other. 
The present study was undertaken to identify and ascertain 
the sensit ivity of selective biochemical markers for specific diagnosis 
of Fe deficiency and that of Pb exposure. Fur ther . l t was aimed 
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to evaluate the influence of iron deficiency on uptake and retention 
of lead. The weanling rats bred in l .T .R.C. animal house facility 
were used in the study. The rats were made Fe deficient by feeding 
Fe deficient diet for a period of 3 to 6 weeks. The exposure to 
Pb was initiated by exposure to 0.1% lead acetate in drinking water 
for 3 to 6 weeks. 
Dietary Fe deficiency significantly increased the activity of 
blood ALAD which was more pronounced at 3 weeks than at 6 weeks. 
The exposure to Pb on the other hand,significantly inhibited this 
enzyme,the levels of which were of almost similar order at both 
time intervals examined. However,the Pb induced inhibition in ALAD 
was completely offset by Fe deficiency in animals exposed to Pb 
and fed Fe deficient diet . 
Thus,while Fe deficiency increased the activity of blood ALAD, 
the Pb exposure decreased it and their effects seem to be antago-
nistic to eachother. The observation emphasizes the need for caution 
in using this parameter as a biological indicator of Pb exposure 
during Fe deficiency,a situation not uncommon particularly in the 
developing countries. 
The increased ALAD activity is not likely to be due to a subs-
trate concentration effect. The urinary ALA levels however, were 
significantly elevated in both the situations which suggests that 
two different phenomena might operate in Fe deficiency and Pb 
poisoning. The first relates to the inhibition of blood ALAD by Pb 
resulting in enhanced urinary excretion of its substrate , ALA. The 
other possibility is that due to the increase in bood ALAD activity 
during Fe deficiency,the physiological demand for ALA may also 
go-up which might necessitate increased production of ALA through 
ALA synthetase. The production of ALA might outpace the utilization 
of this substrate by Fe deficiency induced blood ALAD-resulting 
in the increased excretion of urinary ALA. 
The Pb exposure caused elevation in blood ZPP level which 
was proportional to the duration of exposure. The Pb induced increase 
in blood ZPP was more marked in animals fed Fe deficient d ie t . 
The Fe deficiency alone however, had no effect on blood ZPP level. 
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The blood GSH-Px level decreased while the urinary excretion 
of ALA increased significantly during Fe deficiency or Pb exposure. 
While the combination of the two factors further increased the urinary 
excretion of ALA,it did not show any synergistic effect on blood 
GSH-Px levels . The inhibitory effect of Fe deficiency or Pb intoxica-
tion on the red blood cell GSH-Px suggests marked oxidative s t ress 
to these cells under both the conditions. 
Plasma ceruloplasmin-a copper binding protein was significantly 
lowered by Fe deficiency or Pb exposure and a synergistic effect 
was observed in animals exposed to Pb and fed Fe deficient diet . 
The total plasma cholesterol level increased significantly in response 
to Fe deficiency or prolonged Pb exposure. 
The feeding of Fe deficient diet decreased the activity of SDH 
in muscle and liver but increased in kidney. The exposure to Pb 
in animals fed normal diet inhibited the hepatic SDH only. The act i -
vity of SDH, a Fe dependent enzyme altered in muscle, l iver and 
kidney during dietary Fe deficiency. The lowering of muscular SDH 
reflects a direct effect of Fe deficiency and may be regarded as 
its specific indicator. However,this effect was countered by the 
concurrent exposure to Pb. Though, Fe containing enzymes or those 
requiring its presence for optimal activity account for a very small 
proportion of the total body Fe, there is evidence that impaired 
function of such enzymes and associated metabolic pathway may result 
from Fe deficiency. 
The animals fed Fe deficient diet showed an increase in the 
activity of hepatic succinate cytochrome C reductase after 3 weeks 
which returned to normal during next 3 weeks. However,the effect 
of Fe deficiency on hepatic succinate cytochrome C reductase remained 
predominent in animals exposed to Pb and fed Fe deficient diet , 
while Pb alone had no influence on this enzyme. The fact that hepatic 
mitochondrial succinate cytochrome C reductase activity increased 
during Fe deficiency but not upon Pb exposure shows that Pb does 
not influence the mitochondrial enzyme systems. Nevertheless, Fe 
deficiency does not cause general decrease in the levels of mitochon-
drial constituents despite marked structural changes in liver mitochon-
dr ia . 
The feeding of Fe deficient diet during Pb exposure significantly 
increased the uptake of Pb in blood. The accumulation of Pb in 
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l lver , kidney .spleen and femur also increased with the duration of 
Pb exposure. The dietary deficiency of Fe significantly enhanced 
Pb accumulation which was also related to the duration of treatment. 
The fact that Fe deficient diet during Pb exposure significantly 
enhanced the uptake and retention of Pb in various organs and flat 
bone strongly suggest that under physiological conditions, Pb and 
Fe share common gastrointestinal absorption pathway and the 
deficiency of Fe increases the body burden of Pb. 
The feeding of Fe deficient diet decreased the endogenous hepatic 
and renal Zn levels,which was significant after 6 weeks. The exposure 
to Pb also decreased the hepatic Zn both at 3 and 6 weeks, while 
it increased the renal Zn during first 3 weeks only. However,the 
animals administered Pb and fed Fe deficient diet showed an increase 
in hepatic zn level as compared to those fed Fe deficient diet alone 
at 6 weeks and a decrease in renal Zn as compared to those exposed 
to Pb and maintained on normal diet at 3 weeks. Spleen Zn levels 
remained unaffected by all the treatments. 
The observation that there was no synergistic effect of Fe 
deficiency and Pb exposure on hepatic and renal Cu levels , suggests 
that homeostasis of Cu is maintained in these organs despite the 
dual insult. 
The preisent study has shown that decrease in blood-GSH-Px, 
PCV.Plasmaceruloplasmin and -Fe levels and increase in urinary 
excretion of ALA,plasmacholesterol and-total iron binding capacity 
are common characterst ics of both Fe deficiency and Pb intoxication 
and thus have limited use as specific diagnostic parameter for either 
of them. However .increase in the activity of blood ALAD with no 
change in ZPP level appears to be specific effect of Fe deficiency. 
On the other hand, inhibition in the activity of blood ALAD with 
an increase in ZPP level may serve as diagnostic indicator of Pb 
intoxication. Even in situations where Pb poisoning and Fe deficiency 
co-exist one would expect significantly higher activity of blood 
ALAD. 
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Further attempts would be made to screen other enzymes of 
heme metabolism and glutathione metabolism for identification of 
alternate diagnostic parameters. Also,efficacy of newly synthesized 
chelating agents to mobilized Pb from Pb poisoned models will be 
evaluated. Finally, influence of iron deficiency in chelating therapy 
modulation would be studied. 
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